Goldman Sachs
WST icon

Goldman Sachs’s West Pharmaceutical WST Stock Holding History

Goldman Sachs’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,000
Closed -$9.09M – 5560
2020
Q2 		$9.09M Hold
40,000
– – ﹤0.01% 2347
2020
Q1 		$6.09M Sell
40,000
-5,000
-11% -$770K ﹤0.01% 2487
2019
Q4 		$6.76M Buy
+45,000
New +$6.55M ﹤0.01% 2725
2014
Q1 		– Sell
-2,200
Closed -$108K – 6954
2013
Q4 		$108K Buy
+2,200
New +$103K ﹤0.01% 6250

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs's WST Position: Q2 2026 in Review

Goldman Sachs increased its West Pharmaceutical (WST) stake by 12% in Q2 2026, buying an estimated $26.6M and bringing the position to 814,772 shares worth $293M. The position accounts for 0.03% of the portfolio, ranked #605.

Goldman Sachs first reported a position in WST in Q2 2013 and has held it in 53 quarters since. The position peaked at $367M in Q3 2020. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Goldman Sachs held 814,772 shares of West Pharmaceutical worth $293M as of Q2 2026.
  • Goldman Sachs bought 87,155 West Pharmaceutical shares in Q2 2026, an estimated $26.6M.
  • West Pharmaceutical made up 0.03% of Goldman Sachs's portfolio in Q2 2026, its #605 holding.
  • Goldman Sachs first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's West Pharmaceutical position peaked at $367M in Q3 2020.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.